ALPHEUS MEDICAL
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers. Alpheus Medical also provides a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM).
ALPHEUS MEDICAL
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2021-01-01
Address:
Oakdale, Pennsylvania, United States
Country:
United States
Website Url:
http://www.alpheusmedical.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Euro CrUX Dataset CrUX Top 10m
Similar Organizations
Grail
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Sionna Therapeutics
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
SonALAsense
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
Transition Bio
Transition Bio provides condensate technology for drug discovery and diagnostics.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
BrightEdge Fund
BrightEdge Fund investment in Series A - Alpheus Medical
Action Potential Venture Capital
Action Potential Venture Capital investment in Series A - Alpheus Medical
Medtech Convergence Fund
Medtech Convergence Fund investment in Series A - Alpheus Medical
SV Health Investors
SV Health Investors investment in Series A - Alpheus Medical
OrbiMed
OrbiMed investment in Series A - Alpheus Medical
Action Potential Venture Capital
Action Potential Venture Capital investment in Series A - Alpheus Medical
BrightEdge Fund
BrightEdge Fund investment in Series A - Alpheus Medical
SV Health Investors
SV Health Investors investment in Series A - Alpheus Medical
OrbiMed
OrbiMed investment in Series A - Alpheus Medical
National Brain Tumor Society
National Brain Tumor Society investment in Series A - Alpheus Medical
Official Site Inspections
http://www.alpheusmedical.com
- Host name: ec2-3-134-65-21.us-east-2.compute.amazonaws.com
- IP address: 3.134.65.21
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Alpheus Medical"
Brain Cancer Clinical Trial | Alpheus Medical
Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers.See details»
Alpheus Medical - Crunchbase Company Profile
Contact Email [email protected] Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers. Alpheus Medical also provides a non-invasive drug-device combination for outpatient treatment of …See details»
Alpheus Medical, Inc | LinkedIn
Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers.See details»
Leadership Team - Alpheus Medical
Vijay has founded or co-founded multiple companies and has raised tens of millions in funding. He is a tri-fellowship trained brain tumor surgeon and is a pioneer in complex brain tumor surgery.See details»
Alpheus Medical closes $16m in series A financing
Nov 17, 2021 Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American …See details»
Alpheus Medical - Overview, News & Similar companies - ZoomInfo
Alpheus Medical contact info: Phone number: (310) 413-4338 Website: www.alpheusmedical.com What does Alpheus Medical do? Founded in 2018, and based in Oakdale, MN, Alpheus …See details»
Alpheus Medical Closes $16M In Series A Financing For Novel …
Alpheus Medical's work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American Cancer Society and …See details»
Alpheus Medical - Funding, Financials, Valuation & Investors
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.See details»
FDA Grants Alpheus Medical Orphan Drug and Fast Track …
Jul 13, 2022 The company is currently enrolling patients in a multi-center Phase 1 clinical trial for the treatment of recurrent glioblastoma (GBM). OAKDALE, Minn., July 13, 2022 /PRNewswire/ …See details»
FDA Grants Alpheus Medical Orphan Drug and Fast Track …
See original press release here.. OAKDALE, Minn., July 13, 2022 /PRNewswire/ -- Alpheusâ„¢ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) …See details»
Alpheus Medical - VentureRadar
"Alpheusâ„¢ Medical, Inc., is developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers. The company's lead product utilizes a novel, non-invasive drug-device …See details»
Investors - Alpheus Medical
Alpheus Medical Inc. is supported by OrbiMed Advisors, Action Potential Venture, Medtech Convergence Fund, the Brain Tumor Investment Fund, and BrightEdge.See details»
Alpheus Medical Closes $16M In Series A Financing For Novel …
Nov 17, 2021 Learn more at www.alpheusmedical.com. MEDIA CONTACT: Carla Benigni SPRIG Consulting, LLC +1 (847) 951-7430 [email protected] SOURCE Alpheus Medical, Inc. …See details»
Alpheus Medical Treats First Patients in First-In-Human ... - BioSpace
Nov 10, 2022 Milestone arrives as the company closes a $14 million follow-on Series A financing round to expand the clinical program for high-grade gliomas, including glioblastomas, and …See details»
Alpheus Medical Treats First Patients in First-In-Human Clinical …
Nov 10, 2022 Alpheus Medical, Inc, is a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers. The company's lead …See details»
Alpheus Medical Closes $16M in Series A Financing for Novel …
Nov 17, 2021 Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American …See details»
Alpheus Medical Announces Formation of World-Class Scientific …
OAKDALE, Minn., March 2, 2022 /PRNewswire/ — Alpheusâ„¢ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body …See details»
Formation of Advisory Board to Support Development of Novel …
Mar 2, 2022 Learn more at www.alpheusmedical.com. SOURCE Alpheus Medical, Inc. RECENT NEWS. Alpheus Medical Announces Positive Phase 1/2 Trial Results November 24, 2024; …See details»
Alpheus Medical Announces Positive Phase 1/2 Trial Results for …
Nov 24, 2024 Learn more at www.alpheusmedical.com. Media Contact Carla Benigni [email protected] SOURCE Alpheus Medical. WANT YOUR COMPANY'S NEWS FEATURED ON …See details»
News about the sonodynamic brain cancer treatment
Nov 17, 2021 RECENT NEWS. First Treated Patient in First-In-Human Clinical Trial for Novel Brain Cancer Treatment November 10, 2022; FDA Grants Alpheus Medical Orphan Drug and …See details»